DrugChatter is a product of thinkBiotech LLC,
and is managed by Yali Friedman, Ph.D.
Dr. Friedman was also publisher and chief editor of the Journal of Commercial
Biotechnology for many years. His first book, Building Biotechnology,
is used as a course text in dozens of biotechnology programs. His other
books include Best Practices in Biotechnology Education and
Best Practices in Biotechnology Business Development.
Dr. Friedman has strong exposure to leading issues in
international biotechnology. He is lead editorial consultant for
Scientific American's worldVIEW, a global biotechnology perspective
profiling biotechnology industries and innovation capacity in dozens of
countries, and has been invited to participate in biotechnology industry
development forums for international groups such as APEC and for
individual countries such as Japan, Canada, Germany, the Philippines,